Sanofi agreed to buy Blueprint Medicines for at least US$9.1 billion as the French drugmaker expands further in rare immunological ...
Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks ...
Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks ...
Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new ...
A federal jury has convicted the accused mastermind behind a murder-for-hire plot of all charges brought against him in the ...
The Danish drugmaker alleges misrepresentations by KBP Biosciences founder Huang Zhenhua about the success of its kidney drug PHARMA giant ...
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the ...
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the ...
In the past several decades, we've seen medical innovations for just about every diagnosis. However, in the realm of brain ...
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker ...
